Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
42 Cards in this Set
- Front
- Back
Amphotericin B MOA? 2) absorption 3) plasma protein binding?
|
binds to ergosterol in the membrane (some binding to humans occurs -> toxicity). 2) poorly absorbed in the GI tract and CNS (but used for meningitides) 3) 90%, mostly to beta-lipoprotein
|
|
Amphotericin B is complexed with what for IV? Excretion?
|
To bile salt dexoycholate. Metabolized and excreted in kidneys but hepatic/renal impairment does not alter blood levels much.
|
|
Amphotericin B adverse effects (4)
|
1) renal impairment seen in almost all (dec. renal perfusion, possibly ATN). 2) abnormal liver function. 3) anemia from reduced erythropoietin. 4) Infusion related toxicity with all sorts of stuff. Pre-medicate with meperidine and acetaminophen or corticosteroids
|
|
Amphotericin B has broad spectrum but less sensitive to what? Resistant?
|
Candida lusitaniae (works for albicans though). Fusarium resistant
|
|
Nystatin structure? Administration? Use?
|
forms pores like Amphotericin B. 2) Too toxic for internal -> topical. 3) Candida for oropharyngeal thrush and vaginal candidiasis
|
|
Azoles, name the two and what was written in the syllabus about them. Yeah I know.
|
1) Imidazoles have the greater effect on human sterol synthesis so more side effects. 2) Triazoles are more slowly metabolized.
|
|
Azoles MOA? Fungi-?
|
Reduce ergosterol synthesis and inhibit P450 enzyme C-14 demthylase. Fungiostatic
|
|
Azoles absorption (3 specific drugs mentioned). Distribution? Metabolism?
|
Variable absorption. Ketoconazole and Itraconazole depend on the pH of stomach. Fluconazole is well absorbed. 2) Fluconazole penetrates even into the eyes, joints, CNS. 3) All in the liver
|
|
Ketoconazole absorption? Effects (3)?
|
Requires low stomach pH. 2) teratogenic, inhibits adrenal and gonadal steroid synthesis so reverses hirsutims in women, and alters metabolism of other drugs leading to toxicity (cyclosporine)
|
|
Ketoconazole drug interactions (3)
|
1) Antacids and H2 blockers block absorption. 2) Rifamycins increase metab of ketoconazole. 3) inhibition of P450s increases other drugs like cyclosporine
|
|
Ketonconazole uses (4) and replaced by what?
|
Remember that this is for mild stuff. 1) oral thrush. 2) mild histo (non-CNS). 3)mild blasto. 4) Onychomycosis. Replaced by itraconazole
|
|
Itraconazole similar to what? Different how? Clinical uses (3)
|
Similar to ketoconazole but NO interaction with mammalian P450s. 1) Dermatophytoses and oncyomycoses. 2) activity against aspergillus. 3) preferred against histo, blasto, and sporotrichosis
|
|
Fluconizole solubility? Distribution? DOC for? Prophylactic for?
|
1) water soluble. 2) Good CNS penetration. 3) DOC for cryptococcal meningitis. 4) prophylactic for fungal disease in bone marrow
|
|
Voriconazole similar to? Excellent activity against? More effective than ampho for?
|
Itraconazole. Excellent activity against Candida. More effective than ampho against aspergillus
|
|
Clotrimazole use? 2 uses?
|
topical use. Lozenges taste better than Nystatin or OTC for vaginal yeast
|
|
Miconazole use? OTC for?
|
1) topical. 2) athlete's foot
|
|
Flucytosine MOA? Fungi-?
|
Transported by permease. Deamidated into 5-fluorouracil (anti-metabolite) by cytosine deaminase (which host cells lack). 5-FU blocks DNA/RNA synthesis. Fungistatic
|
|
Flucytosine adverse effects (7)?
|
Metabolism into 5-FU by gut flora causes: 1) antineoplastic effects. 2) bone marrow toxicity. 3) anemia. 4) leucopenia. 5) thrombocytopenia. 6) nausea. 7) skin rash
|
|
Flucytosine Clinical use?
|
Only in combination therapy b/c resistance develops quickly. Effective synergy with amphoB for cryptococcal meningitis in AIDS
|
|
Griseofulvin MOA?
|
Inhibits fungal mitosis by disrupting the mitotic spindle by interacting with polymerized microtubles and intermediate filaments.
|
|
Griseofulvin solubility? Excretion? Toxicity?
|
Water insoluble. 2) excreted in urine. 3) low toxicity
|
|
Terbinafine MOA? Administration? Effect?
|
1) interferes with ergosterol synthesis by inhibiting squalene epoxide -> toxic. 2) topical or oral use with large first pass effect. 3) accumulates in nails, skin, and fat
|
|
Terbinafine clinical use? Duration of Tx?
|
more effective than itraconazole for nail fungus. 3 months
|
|
Echinocandins (caspofungin) MOA? Protein binding?
|
Inhibits formation of cell wall by binding beta1, 3-D-glucan synthesis. 2) Highly bound to albumin
|
|
Echinocandins (caspofungin) Degradation? Elimination? Solubility?
|
1) Spontaneously degraded and conjugation. 2) Kidneys. 3) water-soluble, semi-synthetic lipoprotein
|
|
Echinocandins (caspofungin) clinical use (2)? Adverse effects (3 main groups, 1 minor)
|
Deep candidiases and aspergillosis. 1) phlebitis/thrombophlebitis. 2) HA. 3) fever/chills. 4) N/V, diarrhea, rash
|
|
Drug for immunocompromised Aspergillosis
|
ampho B
|
|
Drug for competant aspergillosis
|
ampho B or itraconazole
|
|
Drug for rapid or CNS blastomycosis
|
amphoB
|
|
Drug for slow or non-CNS blastomycosis
|
itraconazole or ketoconazole
|
|
Drug for Coccidioidomycosis rapid
|
amphoB
|
|
Drug for Coccidioidomycosis indolent
|
Azole
|
|
Drug for Coccidioidomycosis Meningeal
|
Fluconazole, intrathecal AmphoB
|
|
Drug for crypto
|
AmphoB +/- flucytosine
|
|
drug for crypto maintenance
|
Fluconazole, intrathecal AmphoB
|
|
drug for chronic pulmonary histoplasmosis
|
Itraconazole
|
|
Drug for rapid or CNS histoplasmosis
|
AmphoB
|
|
drug for indolent or maintenance histoplasmosis
|
Itraconazole
|
|
Drug for mucormycosis
|
AmphoB
|
|
Drug for Pseudallescheriasis
|
Itraconazole
|
|
Drug for cutaneous sporotrichosis
|
Iodide or Itraconazole
|
|
Drug for extracutaneous sporotrichosis
|
AmphoB or itraconazole
|